The observation that NfL is significantly elevated in prodromal/manifest versus premanifest HD cross-sectionally and is positively associated with clinical markers of disease severity, is in keeping with data from a number of prior studies [15, 17, 18]. The gene discussed is NEFL; the disease is Huntington disease.